BNC210是一种α7尼古丁受体调节器,用于创伤后应激障碍
Spyridon Papapetropoulos1, Elizabeth Doolin1, Susan O'Connor1
1Bionomics Limited, Adelaide, SA, Australia.
NEJM evidence
|December 8, 2024
概括
BNC210是一种治疗创伤后应激障碍 (PTSD) 的新疗法,在2b期试验中,与安慰剂相比,PTSD症状显著改善. 需要进一步的研究来证实其临床效用.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 创伤后应激障碍 (PTSD) 是一种普遍且使人虚弱的精神疾病.
- BNC210是一种针对7尼古丁乙胆受体的试验性药物,用于PTSD治疗.
研究的目的:
- 评估BNC210在被诊断患有PTSD的患者中的疗效和安全性.
- 为了评估PTSD症状严重程度的变化,使用DSM-5 (CAPS-5) 临床医生管理的PTSD尺度进行评估.
主要方法:
- 一个随机的,双盲的,安慰剂控制的2b期试验 (ATTUNE) 涉及182名18至75岁的患者.
- 患者接受了BNC210 (900毫克每天两次) 或安慰剂12周.
- 主要终点:CAPS-5总得分从基线到第12周的变化.
主要成果:
- 在第12周,与安慰剂相比,BNC210显示了CAPS-5得分的统计学上显著改善 (LS平均差异: -4.03,P=0.048).
- 早在第4周就观察到早期的疗效迹象.
- 在抑郁症状和失眠方面也注意到改善,尽管头痛和恶心等不良事件在BNC210中更为常见.
结论:
- 在12周内,BNC210有效地改善了PTSD症状严重程度.
- 这项研究支持在更大的试验中进行进一步的研究,以确定BNC210在PTSD治疗中的临床效用.
相关概念视频
Cholinergic Antagonists: Therapeutic Uses
1.7K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.7K
Drugs Affecting Neurotransmitter Release or Uptake
1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Anxiolytic Drugs: Overview
1.5K
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
1.5K
Anxiolytic Drugs: Benzodiazepines and Buspirone
3.1K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
3.1K
Post-traumatic Stress Disorder
978
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
978


